|
Mar 17
|
30 Biggest Biotechnology Companies in the World
|
|
Mar 14
|
Exploring How Jazz Pharmaceuticals Honored U.S. Black History Month
|
|
Mar 14
|
Unlocking Jazz Pharmaceuticals' Potential: A Roadmap for Growth
|
|
Mar 13
|
7 Biotech Stocks to Buy as Sector Rotation Ramps Up
|
|
Mar 12
|
11 Stocks Insiders are Buying Now
|
|
Mar 12
|
Jazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on Tuesday, March 19, 2024
|
|
Mar 12
|
Jazz Pharmaceuticals (NASDAQ:JAZZ) shareholders have endured a 32% loss from investing in the stock three years ago
|
|
Mar 7
|
Q4 2023 Zymeworks Inc Earnings Call
|
|
Mar 7
|
10 Mid-Cap Stocks with Insider Purchases
|
|
Jan 13
|
4 Remarkable Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip
|
|
Dec 22
|
Jazz Pharmaceuticals' (JAZZ) PTSD Drug Misses Study Goals
|
|
Dec 22
|
Jazz Pharmaceuticals' Post-Traumatic Stress Disorder Drug Disappoints In Mid-Stage Study
|
|
Dec 21
|
Jazz Pharmaceuticals Provides Update on Phase 2 Trial of Investigational JZP150 in Adult Patients with Post-Traumatic Stress Disorder
|
|
Dec 20
|
Jazz Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 20
|
3 No-Brainer Stocks to Buy With $500 Right Now
|
|
Dec 8
|
Jazz Pharmaceuticals Presents Updated Phase 2a Data at SABCS 2023 Showcasing Potential of Zanidatamab in HER2+/HR+ Metastatic Breast Cancer
|
|
Dec 8
|
Why Is Jazz (JAZZ) Up 2.6% Since Last Earnings Report?
|
|
Dec 8
|
Jazz Pharmaceuticals' 2022 Corporate Sustainability and Social Impact Report: Serving our Global Communities
|
|
Dec 1
|
Jazz Pharmaceuticals to Present Long-Term and Real-World Data Emphasizing Commitment to Treatment-Resistant Epilepsy at the 2023 American Epilepsy Society Annual Meeting
|
|
Nov 30
|
Jazz Pharmaceuticals to Present New Data Highlighting Advancements in Solid Tumors and Rare Blood Cancers at Upcoming Oncology Meetings
|